Inventor · disambiguated record
Zhuyan Guo
Also filed as: GUO ZHUYAN
27 granted patents·9 pending applications·166 citations·filing 2002–2023
95Inventor score
Files withSCHERING CORP12MERCK SHARP & DOHME11MERCK SHARP & DOHME LLC5SANOFI SA2CHELLIAH MARIAPPAN V1
Top patents by PatentIndex Score
36 records- 0195US7488745B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2007·Granted Feb 10, 2009·23 cites·34 claims
- 0292US7504424B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2006·Granted Mar 17, 2009·24 cites·3 claims
- 0391US7482370B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 27, 2009·20 cites·79 claims
- 0490US7884107B2Substituted piperidines that increase P53 activity and the uses thereofMERCK·Filed 2007·Granted Feb 8, 2011·32 cites·36 claims
- 0588US7879890B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Feb 1, 2011·6 cites·11 claims
- 0686US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0786US7687527B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 30, 2010·8 cites·9 claims
- 0884US9809545B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·4 cites·7 claims
- 0984US8987195B2HCV NS3 protease inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 24, 2015·9 cites·27 claims
- 1084US7683085B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2008·Granted Mar 23, 2010·6 cites·10 claims
- 1183US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 1282US7652020B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Jan 26, 2010·5 cites·48 claims
- 1381US12338219B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jun 24, 2025·1 cites·16 claims
- 1479US9783530B2Factor Xla inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 10, 2017·2 cites·14 claims
- 1578US10934294B2Substituted pyrazolo[3,4-d]pyrimidines as PDE9 inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted Mar 2, 2021·2 cites·13 claims
- 1678US6838466B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2002·Granted Jan 4, 2005·10 cites·41 claims
- 1776US12350270B2Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2020·Granted Jul 8, 2025·1 cites·52 claims
- 1876US10239863B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Mar 26, 2019·1 cites·19 claims
- 1976US10011585B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·2 cites·12 claims
- 2065US9676723B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jun 13, 2017·1 cites·16 claims
- 2165US9663527B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted May 30, 2017·1 cites·14 claims
- 2263US8609676B24, 5, 6-trisubstituted pyrimidine derivatives as factor IXa inhibitorsCHELLIAH MARIAPPAN V·Filed 2010·Granted Dec 17, 2013·1 cites·12 claims
- 2360US2023406885A1Cyclic peptides for trapping interleukin-1 betaMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2460US2025066379A1Antimalarial agentsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2558US2016257668A1Factor XIa InhibitorsSHAO NING·Filed 2014·Application pending·0 cites
- 2657US12427142B2Combination comprising alpelisib and 6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl[oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acidSANOFI SA·Filed 2021·Granted Sep 30, 2025·0 cites·19 claims
- 2755US7598242B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2005·Granted Oct 6, 2009·0 cites·3 claims
- 2855US2023404971A1Combination Comprising Abemaciclib and 6-(2,4-Dichlorophenyl)-5-[4-[(3S)-1-(3-Fluoropropyl)Pyrrolidin-3-yl]Oxyphenyl]-8,9-Dihydro-7H-Benzo[7]Annulene-2-Carboxylic AcidSANOFI SA·Filed 2021·Application pending·0 cites
- 2954US7034057B2Compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2003·Granted Apr 25, 2006·0 cites·2 claims
- 3054US2022017526A1Pyrazolopyrimidine pde9 inhibitorsMERCK SHARP & DOHME·Filed 2019·Application pending·0 cites
- 3150US2009239890A1Spiro substituted cyclopropane compounds for the treatment of inflammatory disordersSCHERING CORP·Filed 2009·Application pending·0 cites
- 3248US2003134846A1Treatment of trypanosoma brucei with farnesyl protein transferase inhibitorsSCHERING CORP·Filed 2002·Application pending·0 cites
- 3347US12247031B2Cyclobutyl pyrazolopyrimidine PDE9 inhibitorsMERCK SHARP & DOHME LLC·Filed 2019·Granted Mar 11, 2025·0 cites·5 claims
- 3446US2016229839A1Factor XIa InhibitorsMERTZ ERIC·Filed 2014·Application pending·0 cites
- 3543US2023139282A1Antimalarial agentsDE LERA RUIZ MANUEL·Filed 2021·Application pending·0 cites
- 3638US10555998B2Inactivated equine influenza virus vaccinesINTERVET INC·Filed 2015·Granted Feb 11, 2020·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Zhuyan Guo files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →